Universal influenza vaccine
AssigneeCambridge Technologies, Inc.
InventorBen Hause
Life of this patent
Estimating the term…
Abstract
Immunogenic compositions for inducing a universal immune response to influenza, and particularly influenza A, by eliciting anti-neuraminidase antibodies which provide protection against heterologous influenza infection. Compositions comprising recombinant expression vectors expressing neuraminidase in cultured cells dispersed in a pharmaceutically-acceptable carrier comprising cell culture media, and optional adjuvant. Methods of inducing immune responses against influenza, and particularly influenza A, by eliciting anti-neuraminidase antibodies in a host animal susceptible to infection.
Claims20
A universal immunogenic composition for inducing an immune response in an animal to influenza after administration, said composition comprising recombinant expression vectors in cultured cells dispersed in a pharmaceutically-acceptable carrier comprising cell culture media and optional adjuvant, said recombinant expression vectors expressing a therapeutically effective amount of neuraminidase.
Dependencies are inferred from the claim text.